×
About 78,546 results

ALLMedicine™ Cirrhosis Center

Research & Reviews  36,841 results

Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis W...
https://doi.org/10.14309/ajg.0000000000001267
The American Journal of Gastroenterology; Sharma S, Saraya A

Apr 12th, 2021 - Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?|2021|Sharma S,Saraya A,|

Per-rectal portal scintigraphy as an alternative measure of hepatic venous pressure gra...
https://doi.org/10.1111/cpf.12703
Clinical Physiology and Functional Imaging; Kotani K, Uchida-Kobayashi S et. al.

Apr 12th, 2021 - Hepatic venous pressure gradient (HVPG) measurement is a gold standard for the diagnosis of portal hypertension but can be invasive and difficult to conduct. Per-rectal portal scintigraphy (PRPS) can estimate portal hemodynamics noninvasively. How...

Neutrophil-to-lymphocyte ratio: an accurate method for diagnosing infection in cirrhosis.
https://doi.org/10.1080/00325481.2021.1916258
Postgraduate Medicine; Magalhães RS, Magalhães J et. al.

Apr 12th, 2021 - : Early diagnosing bacterial infection in cirrhotic patients is critical but challenging. Neutrophil-to-lymphocyte ratio (NLR) reflects systemic inflammation and is an emerging biomarker that replicates cirrhosis' imbalanced immune response. Asses...

Prevention of First Decompensation in Advanced Chronic Liver Disease.
https://doi.org/10.1016/j.cld.2021.01.003
Clinics in Liver Disease; Mandorfer M, Simbrunner B

Apr 11th, 2021 - The first occurrence of decompensation constitutes a watershed moment in the natural history of chronic liver disease; it denotes a point of no return in a relevant proportion of patients. Preventive strategies may profoundly decrease cirrhosis-re...

The Role of Hepatic Venous Pressure Gradient in the Management of Cirrhosis.
https://doi.org/10.1016/j.cld.2021.01.002
Clinics in Liver Disease; Veldhuijzen van Zanten D, Buganza E et. al.

Apr 11th, 2021 - Quantifying the degree of portal hypertension provides useful information to estimate prognosis and to evaluate new therapies for portal hypertension. This quantification is done in clinical practice with the measurement of the hepatic venous pres...

see more →

Guidelines  115 results

Chemical Risk Factors of Primary Liver Cancer: An Update
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801911/
Hepatic Medicine: Evidence and Research; Barsouk A, Thandra KC et. al.

Jan 4th, 2021 - Primary liver cancer has the sixth highest incidence and fourth highest cancer mortality worldwide. Hepatitis B is the leading cause of liver cancer, though its incidence is decreasing with vaccination. Alcohol is the leading cause of liver transp...

AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.
https://doi.org/10.1016/j.cgh.2020.10.034
Clinical Gastroenterology and Hepatology : the Official C... Patton H, Heimbach J et. al.

Jan 4th, 2021 - AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.|2021|Patton H,Heimbach J,McCullough A,|

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achie...
https://doi.org/10.1053/j.gastro.2020.11.051
Gastroenterology Younossi ZM, Corey KE et. al.

Dec 11th, 2020 - Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with global public health impact affecting more than 25% of the global population. NAFLD is associated with significant morbidity and mortality from cirrhosis, h...

AGA Clinical Practice Update on Palliative Care Management in Cirrhosis: Expert Review.
https://doi.org/10.1016/j.cgh.2020.11.027
Clinical Gastroenterology and Hepatology : the Official C... Tandon P, Walling A et. al.

Nov 22nd, 2020 - Care with palliative care principles (aka Palliative Care, PC) is an approach to care that focuses on improving the quality of life of patients and their caregivers who are facing life-limiting illness. It encompasses the assessment and management...

Liver Cancer - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK448337/
StatPearls [Internet]; Recio-Boiles A

Nov 18th, 2020 - Hepatocellular carcinoma is the most common form of primary liver cancer in the United States with three-quarters of primary and secondary liver cancer cases. The trend for both estimated new and instances of death is increasing in parallel to the...

see more →

Drugs  901 results see all →

Clinicaltrials.gov  38,933 results

Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis W...
https://doi.org/10.14309/ajg.0000000000001267
The American Journal of Gastroenterology; Sharma S, Saraya A

Apr 12th, 2021 - Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?|2021|Sharma S,Saraya A,|

Per-rectal portal scintigraphy as an alternative measure of hepatic venous pressure gra...
https://doi.org/10.1111/cpf.12703
Clinical Physiology and Functional Imaging; Kotani K, Uchida-Kobayashi S et. al.

Apr 12th, 2021 - Hepatic venous pressure gradient (HVPG) measurement is a gold standard for the diagnosis of portal hypertension but can be invasive and difficult to conduct. Per-rectal portal scintigraphy (PRPS) can estimate portal hemodynamics noninvasively. How...

Neutrophil-to-lymphocyte ratio: an accurate method for diagnosing infection in cirrhosis.
https://doi.org/10.1080/00325481.2021.1916258
Postgraduate Medicine; Magalhães RS, Magalhães J et. al.

Apr 12th, 2021 - : Early diagnosing bacterial infection in cirrhotic patients is critical but challenging. Neutrophil-to-lymphocyte ratio (NLR) reflects systemic inflammation and is an emerging biomarker that replicates cirrhosis' imbalanced immune response. Asses...

Prevention of First Decompensation in Advanced Chronic Liver Disease.
https://doi.org/10.1016/j.cld.2021.01.003
Clinics in Liver Disease; Mandorfer M, Simbrunner B

Apr 11th, 2021 - The first occurrence of decompensation constitutes a watershed moment in the natural history of chronic liver disease; it denotes a point of no return in a relevant proportion of patients. Preventive strategies may profoundly decrease cirrhosis-re...

The Role of Hepatic Venous Pressure Gradient in the Management of Cirrhosis.
https://doi.org/10.1016/j.cld.2021.01.002
Clinics in Liver Disease; Veldhuijzen van Zanten D, Buganza E et. al.

Apr 11th, 2021 - Quantifying the degree of portal hypertension provides useful information to estimate prognosis and to evaluate new therapies for portal hypertension. This quantification is done in clinical practice with the measurement of the hepatic venous pres...

see more →

News  1,679 results

Bariatric Surgery May Cut Cancer in Obesity With Liver Disease
https://www.medscape.com/viewarticle/948869

Apr 6th, 2021 - In a large cohort of insured working adults with severe obesity and nonalcoholic fatty liver disease (NAFLD), among those who underwent bariatric surgery, the rate of incident cancer was lower during a 10-month median follow-up period. The rate wa...

Patients With Decompensated Cirrhosis Often Lack Advance Care Plans
https://www.medscape.com/viewarticle/947552

Mar 16th, 2021 - (Reuters Health) - Many patients with decompensated cirrhosis do not have advance care plans in place to cover their trajectory of illness through end-of-life care, according to a new study that concludes this may be one reason they receive overly...

New 'Minimal Monitoring' Approach to HCV Treatment May Simplify Care
https://www.medscape.com/viewarticle/947455

Mar 14th, 2021 - A novel minimal monitoring (MINMON) approach to hepatitis C virus (HCV) treatment was safe and achieved sustained virology response (SVR) compared to current clinical standards in treatment-naive patients without evidence of decompensated cirrhosi...

Study Questions Albumin Use in Decompensated Cirrhosis
https://www.medscape.com/viewarticle/946828

Mar 3rd, 2021 - NEW YORK (Reuters Health) - A large new phase-3 study is questioning the widespread use of albumin to treat deadly decompensated cirrhosis, especially when the long-trusted therapy may pose a risk of significant side effects. Dr. Alastair O'Brien ...

Terlipressin Shows Benefit in Hepatorenal Syndrome but Risks Spark Concern
https://www.medscape.com/viewarticle/946833

Mar 3rd, 2021 - NEW YORK (Reuters Health) - Details of the phase-3 CONFIRM trial show the vasopressin analog terlipressin can reverse the effects of type 1 hepatorenal syndrome (HRS-1), although not without potentially serious side effects. The study, published i...

see more →

Patient Education  77 results see all →